Researchers have found that pharmacy benefit managers (PBMs) -- organizations that negotiate access to medicines for most patients in the United States -- steer patients to use their own pharmacies.

~ FDA Breakthrough Therapy designation received for PF614-MPAR ~ ~ PF614-MPAR second clinical trial initiated ~ ~ Lead clinical candidate identified for OUD program ~ ~ PF614 Phase 3 trial poised to ...

The nominees make up the richest presidential administration in modern history ... an anti-malaria drug unproven in treating COVID-19. He has faced criticism over his claims about weight-loss ...